PubMed=10901232; DOI=10.1093/jnen/59.7.607
Rainov N.G., Koch S., Sena-Esteves M., Berens M.E.
Characterization of a canine glioma cell line as related to established experimental brain tumor models.
J. Neuropathol. Exp. Neurol. 59:607-613(2000)

PubMed=22120277; DOI=10.1016/j.wneu.2011.09.005
Inoue S., Ichikawa T., Kurozumi K., Maruo T., Onishi M., Yoshida K., Fujii K., Kambara H., Chiocca E.A., Date I.
Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas.
World Neurosurg. 78:670-682(2012)

PubMed=25190452; DOI=10.1186/s12917-014-0184-9; PMCID=PMC4172958
Pang L.Y., Argyle S.A., Kamida A., Morrison K.O., Argyle D.J.
The long-acting COX-2 inhibitor mavacoxib (Trocoxil TM) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro.
BMC Vet. Res. 10:184.1-184.11(2014)